Local bleomycin injection in the treatment of lymphangioma

European Journal of Pediatric Surgery

Volumn 15, Issue 6, 2005, Pages 383-386

  Baskin, Didem ^a,b   Tander, B ^a   Bankaoglu M ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Bleomycin; Cystic hygroma; Lymphangioma

Indexed keywords

BLEOMYCIN; SCLEROSING AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC LYMPHANGIOMA; DRUG SAFETY; FEMALE; HUMAN; INFANT; INJECTION; LYMPHANGIOMA; MALE; NEWBORN; SCLEROTHERAPY; TREATMENT OUTCOME; ULTRASOUND; WOUND HEALING;

ANTIMETABOLITES, ANTINEOPLASTIC; AXILLA; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRALESIONAL; LYMPHANGIOMA; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; SCLEROTHERAPY;

EID: 30344470761     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872922     Document Type: Article

References (10)

1. Balis FM, Holcenberg JS, Blaney SM. General principles of chemotherapy. In: Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. 4 th ed. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lipincott Williams & Wilkins, 2002: 274-275
2. Dorr RT, von Hoff DD. Drug monographs, bleomycin sulfate. In: Dorr RT, von Hoff DD (eds). Cancer Chemotherapy Handbook. 2 nd ed. Norwalk, Connecticut: Appleton & Lange, 1994: 227-235
3. Feins NR. Lymphatic disorders. In: O'Neill JA, Rowe MI, Grosfeld JL, Fonklasrud EW, Coran AG (eds). Pediatric Surgery. 5th ed. St. Louis, Baltimore, Boston, Calsbad, Chicago, Minneapolis, New York, Philadelphia, Portland, London, Milan, Sydney, Tokyo, Toronto: Mosby, 1998: 1973-1981
4. Jiang JP. Local injection of bleomycin A% in lymphangioma in children. Analysis of 100 cases. Chung Hua Wai Ko Tsa Chih 1989; 27: 741-742, 781
5. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19: 766-773
6. Okada A, Kubota A, Fokuzawa M, Imura K, Kamata S. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg 1992; 27: 440-443
7. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995; 30: 1282-1287
8. Skeel RT, Lachant NA. Antineoplastic drugs and biologic response modifiers: Classification, use and toxicity of clinically useful agents. In: Skeel RT, Lachant NA (eds). Handbook of Cancer Chemotherapy. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 1995: 142-144
9. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Büyükpamukç u N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngo 2003; 67: 795-800
10. Stringel G. Hemangiomas and lymphangiomas. In: Ashcraft KW (ed). Pediatric Surgery. 3 rd ed. Philadelphia, London, New York, St. Louis, Sydney, Toronto: W.B. Saunders Company, 2000: 965-986